These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 5450810)
1. [The results of a clinical study of asafan]. Karev NI; Lichinitser MR; Moroz LV; Astrakhan VI; Beroeva GV; Blokhina NG; Buk IM Vopr Onkol; 1970 May; 16(5):41-5. PubMed ID: 5450810 [No Abstract] [Full Text] [Related]
2. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds]. Kholodnyi MD; Mindlin SS Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329 [No Abstract] [Full Text] [Related]
3. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients]. Chernyĭ VA Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339 [No Abstract] [Full Text] [Related]
5. Clinical trial of peptichemio in solid tumors of childhood. Otten J; Maurus R Cancer Treat Rep; 1978 Jul; 62(7):1015-9. PubMed ID: 356966 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of two weekly dose schedules of 'IC-140'. 4-N, N-bis (2-Chloroethyl) amino phenyl N (P-carboxyphenyl) carbamate, in the treatmentment of solid tumors 1,2. Elias EG; Band PR; Mittelman A; Colsky J; Regelson W; Shnider BI; Hanley JA Oncology; 1975; 31(5-6):273-9. PubMed ID: 1107919 [TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of mitozolomide in ovarian cancer. Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943 [No Abstract] [Full Text] [Related]
8. [A phase I trial of 4'-epiadriamycin]. Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111 [TBL] [Abstract][Full Text] [Related]
9. [Results of a cyclophosphamide therapy in genital and mammary carcinomas]. Naumann R Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155 [No Abstract] [Full Text] [Related]
10. [Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin]. Blokhin NN; Astrakhan VI; Garin AM; Lorie IuI; Blokhina NG; Voznyĭ EK; Karev NI; Kachalov VK; Kuchkarev RN; Lichinshcher MR; Moroz LV Antibiotiki; 1968 Sep; 13(9):771-80. PubMed ID: 4303352 [No Abstract] [Full Text] [Related]
11. [Internal treatment of carcinoma with the cytostatic Proresid]. Schärtl W Munch Med Wochenschr; 1966 Jan; 108(2):112-4. PubMed ID: 5341497 [No Abstract] [Full Text] [Related]
12. [Chemotherapy of malignant tumors using massive-dose administration of Endoxan]. Pigatto JC Munch Med Wochenschr; 1967 Oct; 109(40):2082-4. PubMed ID: 4873942 [No Abstract] [Full Text] [Related]
13. Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma. Kyle RA; Carbone PP; Lynch JJ; Owens AH; Costa G; Silver RT; Cuttner J; Harley JB; Leone LA; Shnider BI; Holland JF Cancer Res; 1967 Mar; 27(3):510-5. PubMed ID: 5336511 [No Abstract] [Full Text] [Related]
14. [1st experiences in the treatment of ovarian tumors with Peptichemio]. Natale N; Mangioni C; Remotti G Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233 [No Abstract] [Full Text] [Related]
15. Effect of glucuronic acid conjugate of aniline mustard on human ovarian and other tumours 'in vitro'. Rao KV; Bhat AV; Bapat CV Indian J Cancer; 1978 Sep; 15(3):21-2. PubMed ID: 575105 [No Abstract] [Full Text] [Related]
16. Evaluation of aniline mustard in patients with multiple myeloma. Kyle RA; Costa G; Cooper MR; Ogawa M; Silver RT; Glidewell O; Holland JF Cancer Res; 1973 May; 33(5):956-60. PubMed ID: 4703127 [No Abstract] [Full Text] [Related]
17. [Results of the clinical use of asalin]. Kruglova GV Vopr Onkol; 1965; 11(10):10-6. PubMed ID: 5872964 [No Abstract] [Full Text] [Related]
18. [Results of 18 months of chemotherapy with Peptichemio]. Battelli T; Bonsignori M; Manocchi P; Perilli A Minerva Med; 1974 Sep; 65(62):3235-43. PubMed ID: 4609310 [No Abstract] [Full Text] [Related]
19. Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer. Ahmann DL; Bisel HF; Hahn RG Cancer Res; 1973 Jul; 33(7):1707-10. PubMed ID: 4578655 [No Abstract] [Full Text] [Related]